Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Simvastatin 10 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Simvastatin 10 mg Tablet belongs to the class of lipid-lowering medications known as HMG-CoA reductase inhibitors (statins). It works by inhibiting the enzyme HMG-CoA reductase in the liver, reducing cholesterol synthesis and increasing the liver's ability to remove low-density lipoprotein cholesterol (LDL-C) from the bloodstream. Simvastatin effectively lowers total cholesterol, LDL-C, and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C). The 10 mg strength is typically used as a starting dose for patients with mild to moderate hyperlipidemia or for long-term maintenance therapy. By controlling dyslipidemia, Simvastatin 10 mg helps prevent atherosclerosis and reduces the risk of cardiovascular events such as heart attack, stroke, and peripheral arterial disease. It is often prescribed alongside lifestyle modifications, including diet and exercise, to achieve optimal lipid control.
Most patients tolerate Simvastatin well. Common side effects may include headache, abdominal pain, constipation, nausea, and mild muscle aches. Rare but serious adverse effects include myopathy, rhabdomyolysis, and elevated liver enzymes. The risk of muscle toxicity may increase when taken with certain medications like strong CYP3A4 inhibitors. Patients should promptly report any unexplained muscle pain, tenderness, or weakness.
Simvastatin 10 mg Tablet is indicated for the treatment of primary hypercholesterolemia, mixed dyslipidemia, and hypertriglyceridemia. It is also used for the primary and secondary prevention of cardiovascular events in patients with coronary artery disease, diabetes, or other high-risk conditions to lower the risk of heart attack and stroke.
Simvastatin 10 mg should be taken under medical supervision and combined with lifestyle modifications for best results. It is contraindicated during pregnancy and breastfeeding, as statins may cause harm to the fetus. The drug should not be used in patients with active liver disease or unexplained persistent elevations in liver enzymes. Alcohol consumption should be limited to reduce liver stress. Regular monitoring of lipid levels and liver function tests is recommended. Patients should avoid grapefruit juice while on therapy, as it can increase Simvastatin levels and the risk of side effects.
Store Simvastatin 10 mg Tablet in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children and pets. Do not use the tablet after the expiry date mentioned on the packaging.
Composition : Simvastatin 20 mg tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (5mg) tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin 20 mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 20 mg + Ezetimibe 10 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Simvastatin 10 mg Tablet is a lipid-lowering (statin) medicine used for the management of high cholesterol, dyslipidemia, and prevention of cardiovascular diseases such as heart attack and stroke. It works by reducing cholesterol production in the liver and improving lipid profiles, making it a widely prescribed product in the cardiovascular and chronic care segment. Its consistent demand among cardiologists and physicians makes it a valuable addition to the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the steady demand for cholesterol-management therapies. Since Simvastatin is commonly prescribed for long-term treatment, it generates regular repeat prescriptions, stable sales volumes, and continuous market demand through retail pharmacies, hospitals, and healthcare institutions.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiovascular and lipid-management segment, including Simvastatin 10 mg Tablet. We provide monopoly rights, quality-assured manufacturing, promotional support, and reliable product supply to help franchise partners expand their business successfully.
Wholesalers and stockists benefit from strong prescription-based demand, long-term patient usage, and widespread acceptance among cardiologists and physicians. As cholesterol management often requires ongoing therapy, this product ensures steady product movement, recurring business opportunities, and sustainable profitability in pharmaceutical distribution.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and lipid-lowering products can contact Cafoli Lifecare to discuss pricing, product availability, monopoly franchise rights, and PCD pharma franchise opportunities. We provide complete support through marketing materials, dependable supply chains, and territory-based business assistance to help partners grow their pharmaceutical business successfully.